Review
Jul 2026
Nanomedicine targeting neuroinflammatory pathways in Alzheimer’s disease: a new frontier in inflammopharmacology
Comparative studies show that interventions based on nanocarrier-based therapies enhance therapeutic efficacy and safety profiles in preclinical AD models, and future directions include integrating AI-driven nano-design, gene and siRNA delivery, and precision neuropharmacology to enable personalized anti-inflammatory t...
Sumit Kaushik, Jamal E. Fatima, Amatul Raheem et al.
· InflammoPharmacology · 1 citation